Kenya Pharmacy and Poisons Board
Nairobi, Kenya
Purpose
To support active surveillance capacity with a focus on working with TB sites to strengthen both the quality and quantity of safety reporting of new antituberculosis medicines such as Bedaquiline, Pretomanid, and Linezolid.
Division
Africa & India Offices, Global Health
Date
June 2026
Region Served
AFRICA
Committed amount
$250,000
Grant topic
Development of Solutions to Improve Global Health, Global Health and Development Public Awareness and Analysis, Pneumonia & Pandemic Preparedness
Duration (months)
12
Grantee location
Nairobi, Kenya
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.